In heart disease, the administration of IL-10 was shown to result in a significant suppression of proinflammatory cytokine synthesis, MMP-9 activity, and the infiltration of inflammatory cells in the myocardium, leading to a reduction in cardiac fibrosis [25,26]. The gene discussed is MMP9; the disease is heart disorder.